Landmark case · Intellectual Property Law · Semester 4

Bayer Corporation v. Union of India

2014 SCC OnLine Bom 1250 · Bombay High Court

The compulsory licence to Natco for sorafenib (Nexavar) under section 84 was upheld: reasonable public requirement, affordable price and working in India were not met.

From topic

Rights, compulsory licences and infringement — Unit II, Intellectual Property Law.

Related sections: